Skip to main content
Clinical Trials/ChiCTR2300076348
ChiCTR2300076348Not yet recruitingPhase 1

环泊酚对脑肿瘤手术患者的麻醉效应和脑保护作用

贵阳市科技健康局1 site in 1 countryStarted: September 27, 2023Last updated:

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor
Locations
1
Primary Endpoint
S100β 蛋白水平

Study Overview

Brief Summary

通过比较环泊酚和丙泊酚在脑肿瘤手术中各项指标的变化,探究两种麻醉镇静药物对患者的麻醉效果、血流动力学和脑保护作用,为临床脑肿瘤手术麻醉药物优化提供依据。

Study Design

Study Type
干预性研究
Primary Purpose
随机平行对照
Masking

Eligibility Criteria

Ages
16 to 80 (—)
Sex
All

Inclusion Criteria

  • 1.经 CT、MRI 确诊脑肿瘤并行手术治疗的患者;
  • 3.BMI 18-30 kg/m2。

Exclusion Criteria

  • 1.合并重要器官严重功能障碍;
  • 3.药物过敏史及精神认知障碍;
  • 4.转移性恶性肿瘤患者。

Arms & Interventions

观察组

对照组

Outcomes

Primary Outcomes

S100β 蛋白水平

Time Frame: 手术结束后 24 h

Secondary Outcomes

  • 血流动力学

Investigators

Sponsor
贵阳市科技健康局

Study Sites (1)

Loading locations...

Similar Trials